<?xml version="1.0" encoding="UTF-8"?>
<ref id="B19">
 <label>19</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Joly</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Maho-Vaillant</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Prost-Squarcioni</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Hebert</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Houivet</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Calbo</surname>
    <given-names>S</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial</article-title>
  <source> Lancet</source>
  <year>2017</year>
  <volume>389</volume>
  <issue>10083</issue>
  <fpage>2031</fpage>
  <lpage>40</lpage>
  <pub-id pub-id-type="pmid">28342637</pub-id>
 </element-citation>
</ref>
